Voyager Therapeutics Inc
NASDAQ:VYGR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.27
10.84
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Voyager Therapeutics Inc
Wall Street
Price Targets
VYGR Price Targets Summary
Voyager Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VYGR
is 17.44 USD
with a low forecast of 11.11 USD and a high forecast of 31.5 USD.
VYGR Last Price Targets
Voyager Therapeutics Inc
The latest public price target was made on Nov 13, 2024 by
Jay Olson
from
Oppenheimer
,
who expects
VYGR
stock to
rise by 213%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Jay Olson
Oppenheimer
|
18
USD
Upside 213% |
1 month ago
Nov 13, 2024
|
Oppenheimer Reiterates Outperform Rating on Voyager Therapeutics (VYGR)
StreetInsider
|
Jack Allen
Robert W. Baird
|
18
USD
Upside 213% |
2 months ago
Sep 25, 2024
|
Baird Reiterates Outperform Rating on Voyager Therapeutics (VYGR)
StreetInsider
|
Laura Chico
Wedbush
|
8
USD
Upside 39% |
7 months ago
May 14, 2024
|
Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
StreetInsider
|
Jim Birchenough
Wells Fargo
|
14
USD
Upside 143% |
11 months ago
Jan 2, 2024
|
Wells Fargo Upgrades Voyager Therapeutics (VYGR) to Overweight
StreetInsider
|
Joon Lee
Truist Financial
|
18
USD
Upside 213% |
1 year ago
May 10, 2023
|
Voyager Therapeutics' Seasoned Management And Leading Adeno-Associated Virus Capsid Platform Impress Bullish Analyst
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VYGR's stock price target?
Price Target
17.44
USD
According to Wall Street analysts, the average 1-year price target for
VYGR
is 17.44 USD
with a low forecast of 11.11 USD and a high forecast of 31.5 USD.
What is Voyager Therapeutics Inc's Revenue forecast?
Projected CAGR
-25%
For the last 8 years the
compound annual growth rate for
Voyager Therapeutics Inc's revenue is
40%.
The projected
CAGR
for the next 4 years is
-25%.
You don't have any saved screeners yet
